Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment


Phase N/A Results

Trial Description

Non-interventional, observational study of physicians' use of Dabigatran etexilate for stroke prevention in patients with atrial fibrillation and mild to moderate renal impairment


Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population



Type Measure Time Frame Safety Issue
Primary creatinine clearance (calculated by Cockcroft Gault-Formula) day 1 No
Primary Creatinine Clearance (Recalculated Using Entries of Age, Gender, Body Weight and Serum Creatinine Made by the Physician) One single observation time point: at the time of prescription before the first intake of dabigatran etexilate No